Skip to main content
. 2019 Feb 6;10(2):535–547. doi: 10.1007/s13300-019-0578-6

Table 9.

Different stage comparison of HOMA-β before and after ABM-MNC therapy

Items (months) Test for heterogeneity Analysis model Test for overall effect WMD or SMD 95% CI
I2 (%) P Z P
3 0 0.37 Fixed 0.22 0.83 − 2.26 (− 22.71, 18.19)
6 0 0.53 Fixed 0.22 0.83 − 1.87 (− 18.83, 15.10)
12 0 0.85 Fixed 1.68 0.09 21.34 (− 3.5, 46.19)